Flaw in fentanyl patches could cause difficulty breathing, possibly death

Link to Article

MSNBC.com

12-Feb-2008 - The trend towards outsourcing and outside partnering to improve drug development is tipped to continue, with the strategy being heralded as the way of the future in new research produced by the Tufts Center for the Study of Drug Development (CSDD).

Link to Article

in-pharmatechnologist.com

After Guilin Pharmaceutical in Guangxi Province, China, began getting complaints about its antimalarial medicine, artesunate, the company decided in 2006 to test some field samples. They turned out to be fake.

"They contained starch," Ni Shizheng, vice president of Guilin Pharmaceutical, said in a recent interview. "Our company didn't have the means to deal with the problem."

Link to Article

IHT.com

Study found clogged arteries in young adults who died of unnatural causes

Link to Article

MSNBC.com

The discovery of a new way that H.I.V. attacks human cells could provide fresh avenues for the development of additional therapies to stop AIDS, scientists say.

Link to Article

NYTimes.com

Link to All Articles

Feb 07 2008, 12:41 PM EST
Applied Biosystems Collaborates with Geospiza and GenomeQuest to Address Next-Gen Sequencing Bioinformatics Hurdles
Applied Biosystems will share file formats, sample data sets, and analysis pipeline info.Full Story

Feb 06 2008, 12:17 PM EST
Fully Transparent Zebrafish Shows How Melanoma Cells Spread to the Skin
Model may also be used to study genetic defects in the brain, heart, and digestive tract as well as stem-cell rejection, according to Cell Stem Cell paper.Full Story

Feb 06 2008, 12:22 PM EST
Apex Bioventures Plans to Take Over Dynogen for $98M
Dynogen shareholders will own about 56% of the newly formed public entity and will be entitled to $46 million in success-based fees.Full Story

Feb 04 2008, 01:20 PM EST
GE Healthcare to Purchase Whatman for About $716M
Transaction marks GE Healthcare's first acquisition attempt within its life science business since the failed buyout of Abbott units.Full Story

Feb 04 2008, 01:21 PM EST
Takeda Commits Over $1B for Japanese Rights to Amgen Clinical Candidates
Corporation will also take over Amgen's Japanese subsidiary, Amgen KK.Full Story

Feb 04 2008, 01:18 PM EST
Amira Inks $425M Deal with GSK Related to Respiratory and Cardiovascular Diseases
Agreement includes FLAP inhibitors with an initial focus on asthma.Full Story

Feb 04 2008, 01:15 PM EST
Seaside Proffers $4.5M to Support Discovery Activities in Fragile X Syndrome at Vanderbilt
Firm has the right to select compounds for clinical development.Full Story

Feb 04 2008, 01:08 PM EST
AMRI Expands Foothold in India with Acquistion of FineKem
Transaction enhances firm's ability to produce custom pilot-scale intermediates.Full Story

Feb 01 2008, 11:21 AM EST
New Biomarker Test Performs Better than PCA3 and PSA
Diagnostic combines PCA3 and three other RNAs including a gene fusion, according to Cancer Research paper.Full Story

Feb 01 2008, 11:18 AM EST
AlgoNomics to Assist Genmab in Assessing UniBody Molecules
AlgoNomics will analyze protein-protein and protein-peptide interactions and use its structure database to evaluate Genmabs antibody scaffolds.Full Story

GenEngNews.com

Link to Article

Pharmaceutical Technology

Link to Article

Pharmaceutical Technology

A surprise finding in a major federal study calls into question a long-held tenet of diabetes care.

Link to Article

NYTimes.com

04-Feb-2008 - Novartis has been given a warning by US regulators detailing significant failures in its investigation into tracking down the source of contamination in some of its vaccines.

Link to Article

In-Pharmatechnologist.com